DUSP26 and cancer: Overall, Fol-PEG-α-CDE (G4, DSC2.9, DSF2, DSP2) should be better than Fol-PEG-α-CDE (G3, DSC2.4, DSF4, DSP4) as a siRNA carrier for cancer treatment, although further detailed study is necessary.